In the last decades, bronchial asthma has represented a main focus of both basic and pharmacological research. In fact, the knowledge about pathophysiological mechanisms and phenotypes as well as the treatment opportunities have substantially increased1. In particular, the introduction of biologic drugs for severe asthma is leading a revolution in terms of pharmacological therapy, by paving the way to the precision medicine approach1
Uncontrolled severe asthma: starting from the unmet needs
Caminati, Marco;Senna, Gianenrico
2019-01-01
Abstract
In the last decades, bronchial asthma has represented a main focus of both basic and pharmacological research. In fact, the knowledge about pathophysiological mechanisms and phenotypes as well as the treatment opportunities have substantially increased1. In particular, the introduction of biologic drugs for severe asthma is leading a revolution in terms of pharmacological therapy, by paving the way to the precision medicine approach1File in questo prodotto:
Non ci sono file associati a questo prodotto.
I documenti in IRIS sono protetti da copyright e tutti i diritti sono riservati, salvo diversa indicazione.